312 related articles for article (PubMed ID: 33630831)
41. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
Pyke AT; Nair N; van den Hurk AF; Burtonclay P; Nguyen S; Barcelon J; Kistler C; Schlebusch S; McMahon J; Moore F
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200386
[TBL] [Abstract][Full Text] [Related]
42. Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells.
Kapczynski DR; Sweeney R; Spackman E; Pantin-Jackwood M; Suarez DL
Virology; 2022 Apr; 569():1-12. PubMed ID: 35217403
[TBL] [Abstract][Full Text] [Related]
43. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates.
Kang YF; Sun C; Zhuang Z; Yuan RY; Zheng Q; Li JP; Zhou PP; Chen XC; Liu Z; Zhang X; Yu XH; Kong XW; Zhu QY; Zhong Q; Xu M; Zhong NS; Zeng YX; Feng GK; Ke C; Zhao JC; Zeng MS
ACS Nano; 2021 Feb; 15(2):2738-2752. PubMed ID: 33464829
[TBL] [Abstract][Full Text] [Related]
44. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.
Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y
mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873
[TBL] [Abstract][Full Text] [Related]
45. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies.
Nguyen HT; Falzarano D; Gerdts V; Liu Q
J Virol; 2021 Aug; 95(18):e0068721. PubMed ID: 34191580
[TBL] [Abstract][Full Text] [Related]
46. The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies.
Durdagi S; Avsar T; Orhan MD; Serhatli M; Balcioglu BK; Ozturk HU; Kayabolen A; Cetin Y; Aydinlik S; Bagci-Onder T; Tekin S; Demirci H; Guzel M; Akdemir A; Calis S; Oktay L; Tolu I; Butun YE; Erdemoglu E; Olkan A; Tokay N; Işık Ş; Ozcan A; Acar E; Buyukkilic S; Yumak Y
Mol Ther; 2022 Feb; 30(2):963-974. PubMed ID: 34678509
[TBL] [Abstract][Full Text] [Related]
47. Hesperidin Is a Potential Inhibitor against SARS-CoV-2 Infection.
Cheng FJ; Huynh TK; Yang CS; Hu DW; Shen YC; Tu CY; Wu YC; Tang CH; Huang WC; Chen Y; Ho CY
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444960
[TBL] [Abstract][Full Text] [Related]
48. Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics.
Chitsike L; Duerksen-Hughes P
Virol J; 2021 Jul; 18(1):154. PubMed ID: 34301275
[TBL] [Abstract][Full Text] [Related]
49. The PIKfyve Inhibitor Apilimod: A Double-Edged Sword against COVID-19.
Baranov MV; Bianchi F; van den Bogaart G
Cells; 2020 Dec; 10(1):. PubMed ID: 33375410
[TBL] [Abstract][Full Text] [Related]
50. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro.
Lee G; Budhathoki S; Lee GY; Oh KJ; Ham YK; Kim YJ; Lim YR; Hoang PT; Lee Y; Lim SW; Kim JM; Cho S; Kim TH; Song JW; Lee S; Kim WK
Viruses; 2021 Apr; 13(4):. PubMed ID: 33918914
[TBL] [Abstract][Full Text] [Related]
51. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
Dieterle ME; Haslwanter D; Bortz RH; Wirchnianski AS; Lasso G; Vergnolle O; Abbasi SA; Fels JM; Laudermilch E; Florez C; Mengotto A; Kimmel D; Malonis RJ; Georgiev G; Quiroz J; Barnhill J; Pirofski LA; Daily JP; Dye JM; Lai JR; Herbert AS; Chandran K; Jangra RK
Cell Host Microbe; 2020 Sep; 28(3):486-496.e6. PubMed ID: 32738193
[TBL] [Abstract][Full Text] [Related]
52. Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 in vitro.
Unal MA; Bitirim CV; Summak GY; Bereketoglu S; Cevher Zeytin I; Besbinar O; Gurcan C; Aydos D; Goksoy E; Kocakaya E; Eran Z; Murat M; Demir N; Aksoy Ozer ZB; Somers J; Demir E; Nazir H; Ozkan SA; Ozkul A; Azap A; Yilmazer A; Akcali KC
Can J Physiol Pharmacol; 2021 May; 99(5):449-460. PubMed ID: 33689451
[TBL] [Abstract][Full Text] [Related]
53. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors.
Singh M; Bansal V; Feschotte C
Cell Rep; 2020 Sep; 32(12):108175. PubMed ID: 32946807
[TBL] [Abstract][Full Text] [Related]
54. An easy method for developing fusion enabled SARS-CoV2 virus fusion mimic (SCFM), bypassing the need of Bio Safety Level (BSL) facility.
Das A; Dutta S; Sharma D; Pal A; Ganguli N; Majumdar SS
Bioengineered; 2021 Dec; 12(1):4407-4419. PubMed ID: 34436976
[TBL] [Abstract][Full Text] [Related]
55. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
Matsuyama S; Nao N; Shirato K; Kawase M; Saito S; Takayama I; Nagata N; Sekizuka T; Katoh H; Kato F; Sakata M; Tahara M; Kutsuna S; Ohmagari N; Kuroda M; Suzuki T; Kageyama T; Takeda M
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7001-7003. PubMed ID: 32165541
[TBL] [Abstract][Full Text] [Related]
56. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
57. DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
Chai KM; Tzeng TT; Shen KY; Liao HC; Lin JJ; Chen MY; Yu GY; Dou HY; Liao CL; Chen HW; Liu SJ
PLoS Negl Trop Dis; 2021 May; 15(5):e0009374. PubMed ID: 34043618
[TBL] [Abstract][Full Text] [Related]
58. Age-Related Susceptibility of Ferrets to SARS-CoV-2 Infection.
Martins M; Fernandes MHV; Joshi LR; Diel DG
J Virol; 2022 Feb; 96(3):e0145521. PubMed ID: 34817200
[TBL] [Abstract][Full Text] [Related]
59. COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis.
Fierabracci A; Arena A; Rossi P
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708112
[TBL] [Abstract][Full Text] [Related]
60. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice.
Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Tian M; Jin N; Li X
Virol J; 2021 Feb; 18(1):46. PubMed ID: 33639976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
